[
  {
    "ts": null,
    "headline": "8 Growth Stocks to Buy That Aren’t Technology. What Makes Them Worth It.",
    "summary": "As tech stocks float at historic highs, it’s a good time to look elsewhere for growth. A Citi screen turned up eight names that are mostly outside the tech sector.",
    "url": "https://finnhub.io/api/news?id=41acfed98d7d1a6ffccf72773db84c327b3c05dfe4162844d7240895b9a266fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756146360,
      "headline": "8 Growth Stocks to Buy That Aren’t Technology. What Makes Them Worth It.",
      "id": 136522246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "As tech stocks float at historic highs, it’s a good time to look elsewhere for growth. A Citi screen turned up eight names that are mostly outside the tech sector.",
      "url": "https://finnhub.io/api/news?id=41acfed98d7d1a6ffccf72773db84c327b3c05dfe4162844d7240895b9a266fb"
    }
  },
  {
    "ts": null,
    "headline": "Natera Shares Rise on the Launch of AI Platform for Precision Oncology",
    "summary": "NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.",
    "url": "https://finnhub.io/api/news?id=015b032fefd112a3857515fd18df6f693b0c19d49565184a5d321bdd1cd17455",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756140720,
      "headline": "Natera Shares Rise on the Launch of AI Platform for Precision Oncology",
      "id": 136522512,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "NTRA shares gain after unveiling its in-house AI platform, built on vast oncology datasets to transform precision cancer care.",
      "url": "https://finnhub.io/api/news?id=015b032fefd112a3857515fd18df6f693b0c19d49565184a5d321bdd1cd17455"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Gains 56.2% in a Year: What's Driving the Rally?",
    "summary": "IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.",
    "url": "https://finnhub.io/api/news?id=795d3b8f8a9ef33cd3b355733d8c8f9b13ba5952f925dd7315301d4e01ab044d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756126020,
      "headline": "IDEXX Gains 56.2% in a Year: What's Driving the Rally?",
      "id": 136508135,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "IDXX shares surge 56.2% in a year, fueled by strong diagnostics growth, cloud software gains and an upbeat 2025 outlook.",
      "url": "https://finnhub.io/api/news?id=795d3b8f8a9ef33cd3b355733d8c8f9b13ba5952f925dd7315301d4e01ab044d"
    }
  },
  {
    "ts": null,
    "headline": "HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?",
    "summary": "Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.",
    "url": "https://finnhub.io/api/news?id=8a343d1124a9db99c6fe2365ad869baf51024ee344d6c1f9130be9afde300a15",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756125060,
      "headline": "HOLX vs. BSX: Which Healthcare Stock Has More Room to Grow?",
      "id": 136508136,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Two MedTech giants, one clear winner. Boston Scientific's momentum outpaces Hologic's cautious rise.",
      "url": "https://finnhub.io/api/news?id=8a343d1124a9db99c6fe2365ad869baf51024ee344d6c1f9130be9afde300a15"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific recalls carotid stents over manufacturing defect",
    "summary": "The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.",
    "url": "https://finnhub.io/api/news?id=80bcc708e7ae39a7df2c0264e385a34ed678d79f11fbe8ec606c64d45d83bd99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756092462,
      "headline": "Boston Scientific recalls carotid stents over manufacturing defect",
      "id": 136522513,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The FDA said the defect could injure blood vessels, damage the stent or release debris that could travel to the brain and cause a stroke.",
      "url": "https://finnhub.io/api/news?id=80bcc708e7ae39a7df2c0264e385a34ed678d79f11fbe8ec606c64d45d83bd99"
    }
  }
]